Delivery Order SPE2DR25D1201-SPE2DR26FAJNC
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 18, 2025, for the supply of Adzenys XR-ODT 18.8 mg tablets (30-unit dose packages) at a ceiling value of $1,022.24. The contract is classified as a firm fixed-price delivery order with an ultimate completion date of September 19, 2025, and carries no set-aside designation, indicating it was awarded through open competition. This delivery order...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for supply of ADZENYS XR ODT tablets (amphetamine extended-release orally disintegrating tablets) at a ceiling value of $1,968.19. This is a firm fixed-price delivery order with no set-aside designation, representing a competitive award under AmerisourceBergen's existing pharmaceutical supply contract. The order is scheduled for completion by September 22, 2025, with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Adzenys XR-ODT 3.1 mg tablets in unit dose packaging (30-count) with a ceiling value of $2,063.20. This is a firm fixed-price delivery order with an ultimate completion date of July 30, 2025, and represents a non-set-aside procurement awarded through competitive bidding. The order will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,865.67 to AmerisourceBergen Drug Corp for the supply of Adzenys XR-ODT 12.5 mg tablets (30-count unit dose packages) with a completion date of September 30, 2025. This is a firm fixed-price, non-set-aside contract performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated...
- This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,770.93 contract is for the supply of ADZENYS XR-ODT 18.8 MG TABLET UD 30S, a pharmaceutical product, with a period of performance through May 1, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Adzenys XR-ODT 18.8 mg tablets in unit-dose packaging (30-count) with a ceiling value of $2,705.69. This firm fixed-price delivery order, with an ultimate completion date of September 30, 2025, represents a non-competitive set-aside award and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award falls under...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Adzenys XR-ODT 18.8 mg tablets in unit-dose packaging of 30 units, with a ceiling value of $1,927.41. The contract was awarded on August 13, 2025, with an ultimate completion date of August 14, 2025, and represents a non-set-aside, competitively awarded transaction. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,504.87 to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Adzenys XR-ODT 9.4 mg tablets in unit-dose packaging (30 tablets). This firm fixed-price delivery order, with an ultimate completion date of September 24, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the...
- This delivery order, awarded on August 18, 2025, represents a competitively awarded, firm fixed-price contract for pharmaceutical supplies valued at $9,107.57. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was selected to supply Adzenys XR ODT tablets (1's, 18.8mg), a medication used in the treatment of attention-deficit/hyperactivity disorder. The contract is classified as a non-set-aside award and carries an ultimate completion...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $2,943.88 by the Defense Logistics Agency's Medical Supply Chain for the supply of ADZENYS XR ODT (orally disintegrating tablets) 6.3mg pharmaceutical product. The contract, awarded on August 15, 2025, with an ultimate completion date of August 18, 2025, utilizes firm fixed pricing under a competitive award with no set-aside designation. The place of performance is listed as the vendor's corporate office location in...
- SPE2DR25D1201Indefinite Delivery Contract
- SPE2DR25D1201-SPE2DR26FAJNCDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,143.14 to AmerisourceBergen Drug Corp for ADZENYS XR-ODT 18.8 mg tablets (30-count unit dose packages) on October 21, 2025, with completion scheduled for October 22, 2025. This firm fixed price contract was competitively awarded without set-aside provisions. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems, and this delivery order represents a child contract issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical. This delivery order falls under AmerisourceBergen Drug Corp's comprehensive $999.999 billion indefinite delivery vehicle with DLA Troop Support Medical (contract SPE2DX), which runs through December 2026 and authorizes the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. ADZENYS XR-ODT is an extended-release formulation of amphetamine mixed salts used in attention-deficit/hyperactivity disorder treatment, reflecting the company's role in providing specialty medications across multiple therapeutic domains to the Defense Health Agency and other federal healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 10/21/25 |